Synopsis of recent research by authors named "Su Fang"
- Su Fang's recent research focuses on the development of targeted therapies for various cancers, including non-small cell lung cancer (NSCLC) and ovarian cancer, investigating mechanisms such as the β-catenin-BMP2 signaling pathway and the MUC1/Wnt/β-catenin pathway to enhance treatment efficacy and reduce resistance.
- The studies also explore the prognostic implications of biomarkers like protein tyrosine phosphatase non-receptor II in hepatocellular carcinoma and novel long noncoding RNAs associated with N6-methyladenosine modifications in serous ovarian carcinoma, indicating potential avenues for personalized medicine.
- Additionally, Su Fang examines the protective effects of natural compounds, such as Gardenia jasminoides polysaccharides, against liver injury and reports on infectious cases of rare pathogens like Nocardia beijingensis, highlighting a diverse range of research interests within cancer therapeutics and infectious diseases.